Jun Ho Jang

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Obstructive Sleep Apnea

Top Venues

Journal of Korean medical science

Annals of laboratory medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Ho Jang, Jin Seok Kim, Cindy Thiow Koon Lim, Nora Joelle Kleinman, Karl-Johan Myren, Alice Wang, Yogesh Patel, Jong Wook Lee
Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry. Journal of Korean medical science 39 (8) (2024)
Jun Ho Jang, Jin Seok Kim, Cindy Thiow Koon Lim, Nora Joelle Kleinman, Karl-Johan Myren, Alice Wang, Yogesh Patel, Jong Wook Lee
Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry. Journal of Korean medical science 39 (8) (2024)
Jin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, Seo-Yeon Ahn, Sung Soo Yoon, Je Hwan Lee, Sung-Hyun Kim, Chul Won Choi, Ho Jin Shin, Min-Kyoung Kim, Jae Hoon Lee, Yeung Chul Mun, Jee Hyun Kong, BokJin Hyun, HyunSun Nam, Eunhye Kim, Min Joo Kwak, Yong Kyun Won, Jong Wook Lee
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. Journal of Korean medical science 38 (41) (2023)
Jun Ho Jang, Roberta Demichelis Gomez, Horia Bumbea, Larysa Nogaieva, Lily Lee Lee Wong, Soo Min Lim, Younsoo Kim, Jihye Park
A phase III, randomised, double-blind, multi-national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria. EJHaem 4 (1) (2022)
Jun Ho Jang, Roberta Demichelis Gomez, Horia Bumbea, Larysa Nogaieva, Lily Lee Lee Wong, Soo Min Lim, Younsoo Kim, Jihye Park
A phase III, randomised, double-blind, multi-national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria. EJHaem 4 (1) (2022)
Jung Yoon, Eun Hye Cho, Jae Won Yun, Hyun-Young Kim, Jun Ho Jang, Hee Jin Kim, Sun Hee Kim
LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31. Annals of laboratory medicine 41 (3) (2021)
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Christian Recher, Andre C Schuh, Michael J Thirman, Jacqueline S Garcia, Courtney D D DiNardo, Vladimir Vorobyev, Nicola Stefano Fracchiolla, Su-Peng Yeh, Jun Ho Jang, Muhit Özcan, Kazuhito Yamamoto, Arpad Illes, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)
Sooin Choi, Yae Jean Kim, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo, Seok Jin Kim, Jun Ho Jang, Kihyun Kim, Chul Won Jung, Hee Jae Huh, Eun Suk Kang
Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults. Annals of laboratory medicine 40 (1) (2020)
Jun Ho Jang, Jin Seok Kim, Sung Soo Yoon, Je Hwan Lee, Yeo Kyeoung Kim, Deog-Yeon Jo, Joo-Seop Chung, Sang Kyun Sohn, Jong Wook Lee
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. Journal of Korean medical science 31 (2) (2016)